European Medicines Agency (EMA) | What's new 中文 关注 孤儿药指定：2-[6-(6,7-二甲氧基喹啉-3-基)吡啶-3-基]-N-[3-(1,1,1-三氟-2-甲基丙-2-基)-1,2-噁唑-5-基]乙酰胺 (zeteletinib) 治疗髓样甲状腺癌，2021/02/19 已撤回 Orphan designation: 2-[6-(6,7-Dimethoxyquinolin-3-yl)pyridin-3-yl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide (zeteletinib) Treatment of medullary thyroid carcinoma, 19/02/2021 Withdrawn ema.europa.eu
